Methotrexate-induced diffuse interstitial pulmonary fibrosis

Southern Medical Journal

Volumn 72, Issue 3, 1979, Pages 313-318

  Bedrossian, Carlos W M ^a,b   Miller, Warren C ^a,b   Luna, Mario A ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; LINCOMYCIN; METHOTREXATE; PREDNISONE; TETRACYCLINE; VINCRISTINE;

ADVERSE DRUG REACTION; AUTOPSY; BRAIN TUMOR; CASE REPORT; FIBROSING ALVEOLITIS; HISTOLOGY; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER; LIVER TOXICITY; LUNG FIBROSIS; MALE GENITAL SYSTEM; PROSTATE CARCINOMA; RESPIRATORY SYSTEM; THERAPY;

AGED; BRAIN NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CASE REPORT; DIAGNOSIS, DIFFERENTIAL; HUMAN; LUNG NEOPLASMS; MALE; METHOTREXATE; MIDDLE AGE; PSORIASIS; PULMONARY FIBROSIS;

EID: 0018762615     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/00007611-197903000-00023     Document Type: Article

References (32)

1. Acute leukemia group B: new treatment schedule with improved survival in childhood leukemia. JAMA 194:74-81, 1965
2. Hertz R, Lewis J Jr, Lipsett MB: Five year experience with the chemotherapy of metastauc choriocarcinoma and related trophoblastic tumors in women. Am J Obstet Gynecol 82:631-640, 1961
3. Jaffe N, Frei E III, Traffis D: Adjuvant methotrexate and citrovarum-factor treatment of osteogenic sarcoma. N Engl J Med 291:994-997, 1974
4. Filip DJ, Logue GL, Harle TS, et al: Pulmonary and hepatic complications of methotrexate therapy of psoriasis. JAMA 216:881-882, 1971
5. Clarysse AM, Cathey WJ, Cartwright GE, et al: Pulmonary disease complicating intermittent therapy with methotrexate. JAMA 209:1861-1864, 1969
6. Schwartz IR, Kajani MK: Methotrexate therapy and pulmonary disease. JAMA 210:1924, 1969
7. Robertson JH: Pneumonia and methotrexate. Br Med J 2:156, 1970
8. Goldman GC, Moschella SL: Severe pneumonitis occurring during methotrexate therapy. Arch Dermatol 103:194-197, 1971
9. Pasquinucci G, Ferrara P, Castellan R: Daunorubicin treatment of methotrexate pneumonia. JAMA 216:2017, 1971
10. Rawbone RG, Shaw MT, Jackson JG, et al: Complication of methotrexate-maintained remission in lymphoblastic leukaemia. Br Med J 4:467-468, 1971
11. Whitcomb ME, Schwarz MI, Tormey DC: Methotrexate pneumonitis: case report and review of the literature. Thorax 27:636-639, 1972
12. Robbins KM, Gribetz I, Strauss L, et al: Pneumonitis in acute lymphatic leukemia during methotrexate therapy. J Pediatr 82:84-88, 1973
13. Everts CE, WestcottJL, Bragg DG: Methotrexate therapy and pulmonary disease. Radiology 107:539-543, 1973
14. Lisbona A, Schwartz I, Lachance C, et al: Methotrexate-induced pulmonary disease. J Can Assoc Radiol 24:215-220, 1973
15. Nesbitt M, Krivit W, Heyn R, et al: Acute and chronic effects of methotrexate on hepatic, pulmonary and skeletal systems. Cancer 37(suppl):1048-1054, 1976
16. Sostman HD, Matthay RA, Putman CE, et al: Methotrexate-induced pneumonitis. Medicine 55:371-388, 1976
17. Sostman HD, Matthay RA, Putman CE: Cytotoxic drug-induced lung disease. Am J Med 62:608-615, 1977
18. Liebow AA: New concepts and entities in pulmonary disease. The Lung. Liebow AA (ed). International Academy of Pathology. Baltimore, Williams and Wilkins Co., 1968, pp 336-351
19. Scadding JG, Hinson KFW: Diffuse fibrosing alveolitis (diffuse interstitial fibrosis of the lungs). Thorax 22:291-304, 1967
20. Bedrossian CWM: Current Data Regarding Bleomycin-induced Pulmonary Toxicity. New York, Intramed Communications, Inc., Vol 2, April 1974 (audio-tape)
21. Fleischman RW, Baker JR, Thompson GR, et al: Bleomycin-induced interstitial pneumonia in dogs. Thorax 26:675-682, 1971
22. Adamson IYR, Bowden DH: The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 77:185-198, 1974
23. Bedrossian CWM, Greenberg SD, Yawn DH, et al: Experimentally induced bleomycin sulfate pulmonary toxicity: histopathologic and ultra-structural study in the pheasant. Arch Pathol 1Mb Med 101:248-254, 1977
24. Gould VE, Miller J: Sclerosing alveolitis induced by cyclophosphamide: ultrastructural observations on alveolar injury ana repair. Am J Pathol 81:513-530, 1975
25. Broughton A, Strong JE, Holoye P, et al: Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassay. Cancer 40:2772-2778, 1977
26. Wyatt PJ, Pittillo RF, Rice LS, et al: Laser differential light scattering bioassay for methotrexate (NSC-740). Cancer Treat Rep 60:225-233, 1976
27. Kinkdale JM Jr, Vogler WR, Dayton PG: Plasma levels of methotrexate in cancer patients as studied by an improved spectrophotofluorometric method. Biochem Med 10:337-350, 1974
28. Myers CE, Lippman ME, Eliot HM, et al: Competitive protein binding assay for methotrexate. Proc Natl Acad Sci USA 72:3683, 1975
29. Raso V, Schreiber R: A rapid and specific radioimmunoassay for methotrexate. Cancer Res 35:1407-1410, 1975
30. Blum RH, Carter SK, Agre K: Clinical review of bleomycin, a new antineoplastic agent. Cancer 31:903-914, 1973
31. Iacovino JR, Leitner J, Abbas AK, et al: Fatal pulmonary reaction from low doses of bleomycin: an idiosyncratic tissue reaction. JAMA 235:1253-1255, 1976
32. Forni AM, Koss LG, Geller W: Cytological study of the effect of cy-clophosphamide on the epithelium of the urinary bladder in man. Cancer 17:1348-1355, 1964